Dyne Therapeutics (DYN) Retained Earnings (2019 - 2026)
Dyne Therapeutics (DYN) recorded quarterly Retained Earnings of -$137000.0 in Q1 2026, up 99.99% quarter-over-quarter from -$1.4 billion in Q4 2025, and up 99.99% on a YoY basis from -$68504.4 in Q1 2025.
Dyne Therapeutics (DYN) Retained Earnings (2019 - 2026) Analysis & Trends
Dyne Therapeutics' Retained Earnings history runs 8 years deep, the most recent figure standing at -$137000.0 for Q1 2026.
- In Q1 2026, Retained Earnings rose 99.99% year-over-year to -$137000.0; the TTM figure through Mar 2026 stood at -$137000.0 (up 99.99% YoY), while the FY2025 annual figure was -$1.4 billion, down 46.97% from the prior year.
- Retained Earnings was -$137000.0 for Q1 2026 at Dyne Therapeutics, up from -$1.4 billion in the prior quarter.
- In the past five years, Retained Earnings ranged from a high of $496000.0 in Q3 2025 to a low of -$1.4 billion in Q4 2025.
- Historically, Retained Earnings has averaged -$442.0 million across 5 years, with a median of -$264.1 million in 2022.
- Biggest YoY gain for Retained Earnings was 100.08% in 2024; the steepest drop was 1362866.07% in 2024.
- A 5-year view of Retained Earnings shows it stood at -$571000.0 in 2022, then plunged by 110672.33% to -$632.5 million in 2023, then plunged by 50.18% to -$949.9 million in 2024, then tumbled by 46.97% to -$1.4 billion in 2025, then surged by 99.99% to -$137000.0 in 2026.
- The last three Retained Earnings figures came in at -$137000.0 (Q1 2026), -$1.4 billion (Q4 2025), and $496000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 814,307.08 Bn | 814,307.05 Bn | - | -153.89 Mn |
| 2 | Belite Bio | 55,320.00 Bn | 55,320.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,149.72 Bn | 17,149.72 Bn | - | -211.85 Mn |
| 4 | Legend Biotech | 3,590.00 Bn | 3,589.71 Bn | 242.10 Mn | 1.00 Bn |
| 5 | Akari Therapeutics | 1,650.72 Bn | 1,650.72 Bn | - | -279.00 Mn |
| 6 | Evaxion A | 1,522.09 Bn | 1,522.07 Bn | - | 130.89 Mn |
| 7 | Psyence Biomedical | 229.39 Bn | 229.38 Bn | - | -1.88 |
| 8 | Vertex Pharmaceuticals | 113.09 Bn | 105.85 Bn | 2.59 Bn | 14.59 Bn |
| 9 | Abivax | 90.15 Bn | 90.15 Bn | - | -838.07 Mn |
| 10 | Dyne Therapeutics | 3.00 Bn | 3.00 Bn | - | -137,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -137,000.00 |
| Dec 31, 2025 | -1.40 Bn |
| Sep 30, 2025 | 496,000.00 |
| Jun 30, 2025 | -1.18 Bn |
| Mar 31, 2025 | -1.07 Bn |
| Dec 31, 2024 | -949.93 Mn |
| Sep 30, 2024 | 478,000.00 |
| Jun 30, 2024 | -763.26 Mn |
| Mar 31, 2024 | -698.16 Mn |
| Dec 31, 2023 | -632.51 Mn |
| Sep 30, 2023 | -565.87 Mn |
| Jun 30, 2023 | -56,000.00 |
| Mar 31, 2023 | -203,000.00 |
| Dec 31, 2022 | -571,000.00 |
| Sep 30, 2022 | -983,000.00 |
| Jun 30, 2022 | -1.16 Mn |
| Mar 31, 2022 | -264.06 Mn |
| Dec 31, 2021 | -269,000.00 |
| Sep 30, 2021 | -176.69 Mn |
| Jun 30, 2021 | -134.11 Mn |